HomeCompareNMFCL vs CL

NMFCL vs CL: Dividend Comparison 2026

NMFCL yields 12.89% · CL yields 2.43%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NMFCL wins by $12.9K in total portfolio value
10 years
NMFCL
NMFCL
● Live price
12.89%
Share price
$25.26
Annual div
$3.26
5Y div CAGR
3.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$53.7K
Annual income
$4,382.25
Full NMFCL calculator →
CL
CL
● Live price
2.43%
Share price
$85.73
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.8K
Annual income
$5,401.96
Full CL calculator →

Portfolio growth — NMFCL vs CL

📍 NMFCL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNMFCLCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NMFCL + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NMFCL pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NMFCL
Annual income on $10K today (after 15% tax)
$1,095.31/yr
After 10yr DRIP, annual income (after tax)
$3,724.91/yr
CL
Annual income on $10K today (after 15% tax)
$206.23/yr
After 10yr DRIP, annual income (after tax)
$4,591.67/yr
At 15% tax rate, CL beats the other by $866.75/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NMFCL + CL for your $10,000?

NMFCL: 50%CL: 50%
100% CL50/50100% NMFCL
Portfolio after 10yr
$47.2K
Annual income
$4,892.10/yr
Blended yield
10.36%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

NMFCL
No analyst data
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+7.8% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NMFCL buys
0
CL buys
0
No recent congressional trades found for NMFCL or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNMFCLCL
Forward yield12.89%2.43%
Annual dividend / share$3.26$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR3.1%28.6%
Portfolio after 10y$53.7K$40.8K
Annual income after 10y$4,382.25$5,401.96
Total dividends collected$26.5K$18.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: NMFCL vs CL ($10,000, DRIP)

YearNMFCL PortfolioNMFCL Income/yrCL PortfolioCL Income/yrGap
1← crossover$12,029$1,328.55$11,012$312.01+$1.0KNMFCL
2$14,410$1,539.80$12,196$412.95+$2.2KNMFCL
3$17,197$1,777.46$13,599$549.66+$3.6KNMFCL
4$20,444$2,043.82$15,288$736.64+$5.2KNMFCL
5$24,216$2,341.23$17,353$995.28+$6.9KNMFCL
6$28,584$2,672.15$19,926$1,357.80+$8.7KNMFCL
7$33,624$3,039.10$23,194$1,873.82+$10.4KNMFCL
8$39,422$3,444.65$27,439$2,621.52+$12.0KNMFCL
9$46,073$3,891.47$33,088$3,727.38+$13.0KNMFCL
10$53,680$4,382.25$40,806$5,401.96+$12.9KNMFCL

NMFCL vs CL: Complete Analysis 2026

NMFCLStock

New Mountain Finance Corporation is a Business Development Company specializing in investments in middle market companies and debt securities at various levels of the capital structure, including first and second lien debt, unsecured notes, bonds, and mezzanine securities. It invests in various industries that include software, education, business services, distribution and logistics, federal services, healthcare services and products, healthcare facilities, energy, media, consumer and industrial services, healthcare Information Technology, Information Technology and services, specialty chemicals and materials, telecommunication, retail, and power generation. It seeks to invest in United States. It typically invests between $10 million and $50 million. Within middle market it seeks to invest in companies having EBITDA between $20 million and $200 million. It prefers to invest in equity interests, such as preferred stock, common stock, warrants, or options received in connection with its debt investments and directly in the equity of private companies. The fund makes investments through both primary originations and open-market secondary purchases. It invests primarily in debt securities that are rated below investment grade and have contractual unlevered returns of 10% to 15%. The firm may also invest in distressed debt and related opportunities and prefers to invest in targets having private equity sponsorship. It seeks to hold its investments between five years and ten years. The fund prefer to have majority stake in companies.

Full NMFCL Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this NMFCL vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NMFCL vs SCHDNMFCL vs JEPINMFCL vs ONMFCL vs KONMFCL vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.